TY  - CONF

T1  - A randomized phase II study of AZ2014 versus everolimus in patients with VEGF refractory metastatic clear cell renal cancer (mRCC).

JO  - Journal of Clinical Oncology

PY  - 2015/03/01

AU  - Powles T

AU  - Wheater MJ

AU  - Din O

AU  - Geldart TR

AU  - Boleti E

AU  - Stockdale A

AU  - Sundar S

AU  - Robinson A

AU  - Ahmed I

AU  - Sarker S-J

AU  - Hussain SA et al

ED  - 

DO  - DOI: 10.1200/jco.2015.33.7_suppl.409

PB  - American Society of Clinical Oncology (ASCO)

VL  - 33

IS  - 7_suppl

SP  - 409

EP  - 409

Y2  - 2024/12/21

ER  -